I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Forconi, F.
25
results:
Articles (Online) X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
FOXO1‐RICTOR AXIS INDUCES AKT PHOSPHORYLATION DURING CLL CE..:
Ondrisova, L.
;
Seda, V.
;
Hoferkova, E.
...
Hematological Oncology. 41 (2023) S2 - p. 54-56 , 2023
Link:
https://doi.org/10.1002/..
?
2
Robust Bruton's tyrosine kinase (BTK) degradation with NX‐5..:
Linton, K.
;
Forconi, F.
;
Lewis, D.
...
Hematological Oncology. 41 (2023) S2 - p. 573-574 , 2023
Link:
https://doi.org/10.1002/..
?
3
Lymph node location and retention properties of DC‐SIGN eng..:
Chiodin, G.
;
Tatterton, D.
;
Zhang, Y.
...
Hematological Oncology. 41 (2023) S2 - p. 256-256 , 2023
Link:
https://doi.org/10.1002/..
?
4
P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACT..:
Owen, R.
;
McCarthy, H.
;
Rule, S.
...
HemaSphere. 6 (2022) - p. 1020-1021 , 2022
Link:
https://doi.org/10.1097/..
?
5
P650: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948, AN ORAL BT..:
Linton, K.
;
Collins, G. P.
;
El-Sharkawi, D.
...
HemaSphere. 6 (2022) - p. 548-549 , 2022
Link:
https://doi.org/10.1097/..
?
6
S145: THE COMBINATION OF IBRUTINIB PLUS VENETOCLAX RESULTS ..:
Hillmen, P.
;
Pitchford, A.
;
Bloor, A.
...
HemaSphere. 6 (2022) - p. 46-47 , 2022
Link:
https://doi.org/10.1097/..
?
7
INTERNATIONAL PROGNOSTIC SCORE FOR EARLY STAGE CHRONIC LYMP..:
Condoluci, A.
;
Terzi di Bergamo, L.
;
Langerbeins, P.
...
Hematological Oncology. 37 (2019) S2 - p. 81-82 , 2019
Link:
https://doi.org/10.1002/..
?
8
IL-10 production by CLL cells is enhanced in the anergic IG..:
Drennan, S
;
D'Avola, A
;
Gao, Y
...
Leukemia. 31 (2016) 8 - p. 1686-1694 , 2016
Link:
https://doi.org/10.1038/..
?
9
Genomic disruption of the histone methyltransferase SETD2 i..:
Parker, H
;
Rose-Zerilli, M J J
;
Larrayoz, M
...
Leukemia. 30 (2016) 11 - p. 2179-2186 , 2016
Link:
https://doi.org/10.1038/..
?
10
PI3Kδ inhibition elicits anti-leukemic effects through Bim-..:
Carter, M J
;
Cox, K L
;
Blakemore, S J
...
Leukemia. 31 (2016) 6 - p. 1423-1433 , 2016
Link:
https://doi.org/10.1038/..
?
11
Phenotypic heterogeneity in IGHV-mutated CLL patients has p..:
Pepper, C
;
Buggins, A G S
;
Jones, C H
...
Leukemia. 29 (2014) 3 - p. 744-747 , 2014
Link:
https://doi.org/10.1038/..
?
12
2‐Chlorodeoxyadenosine in the treatment of relapsed/refract..:
Rondelli, D.
;
Lauria, F.
;
Zinzani, P. L.
...
European Journal of Haematology. 58 (1997) 1 - p. 46-50 , 1997
Link:
https://doi.org/10.1111/..
?
13
Activity of venetoclax in patients with relapsed or refract..:
Kater, Arnon P
;
Arslan, Önder
;
Demirkan, Fatih
...
The Lancet Oncology. 25 (2024) 4 - p. 463-473 , 2024
Link:
https://doi.org/10.1016/..
?
14
Development of a distributed international patient data reg..:
Andritsos, Leslie A.
;
Anghelina, Mirela
;
Neal, Jasmine
...
Leukemia & Lymphoma. 63 (2022) 13 - p. 3021-3031 , 2022
Link:
https://doi.org/10.1080/..
?
15
Hairy cell leukemia and COVID-19 adaptation of treatment gu..:
Grever, Michael
;
Andritsos, Leslie
;
Banerji, Versha
...
Leukemia. 35 (2021) 7 - p. 1864-1872 , 2021
Link:
https://doi.org/10.1038/..
1-15